NCT00024544已完成2 期
A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma
Facet Biotech36 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2001年8月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
- 试验地点
- 36
研究概览
简要总结
The purpose of the study is to evaluate an investigational medication to treat chronic asthma. The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years. Participants in the study will have a number of visits to a research site over an 8-month period. All study-related care and medication is provided to qualified participants at no cost. This includes all visits, examinations and laboratory work.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least a 6-month history of asthma
- •No use of inhaled, oral or injectable steroids for at least 1 month prior to enrollment
排除标准
- •Patients with > 10 pack years of smoking history or smoking within 12 months of study enrollment
- •No significant disease other than asthma
研究者
研究点 (36)
Loading locations...
相似试验
终止
2 期
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaAsthmaNCT06376045Amgen317
招募中
1 期
A Study of MG-K10 in Subjects With AsthmaAsthmaNCT05382910Shanghai Mabgeek Biotech.Co.Ltd180
已完成
2 期
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)Alzheimer's DiseaseNCT00420420Merck Sharp & Dohme LLC144
已完成
2 期
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)SchizophreniaParanoid SchizophreniaNCT00482430Merck Sharp & Dohme LLC50
进行中（未招募）
3 期
Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)Axial SpondyloarthritisNCT06333210Biocad421